US equity markets rallied, buoyed by biotechnology giant Gilead Science Inc saying it was aware of positive data out of a clinical trial being conducted by the National Institute of Allergy and Infectious Diseases' into its Remdesivir antiviral drug for use against the coronavirus- Dow up +532-points or +2.21% The broader S&P500 gained +2.66%, with Energy (up +7.35%) leading nine of the eleven primary sectors higher. Utilities (down -0.92%) and Consumer Staples (-0.41%) were the laggards. The technology-centric NASDAQ gained +3.57%. The small capitalisation Russell 2000 index rallied +4.8%.
